Halozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Helen Torley Sells 20,000 Shares
MarketBeat
Halozyme Therapeutics, Inc. (NASDAQ:HALO - Get Free Report) CEO Helen Torley sold 20,000 shares of the company's stock in a transaction that occurred on Wednesday, July 9th. The shares were sold at an average price of $56.43, for a total value of $1,128,600.00. Following the sale, the chief executive officer directly owned 733,719 shares in the company, valued at approximately $41,403,763.17. This represents a 2.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
NASDAQ:HALO